This work is licensed under a Table 1.
Comparison of baseline characteristics of participants and non-participants among transgender individuals. Values presented with mean (s.d.).
| TW | TM | |||
|---|---|---|---|---|
| Participants (n = 16) | Non-participants (n = 16)a | Participants (n = 27) | Non-participants (n = 22)b | |
| Age (years) | 41.6 (10.5) | 38.2 (8.1) | 33.4 (8.3) | 37.1 (7.17) |
| Weight (kg) | 76.7 (13.2) | 76.9 (10.4) | 73.14 (12.37) | 78.3 (13.4) |
| Cholesterol (mmol/L) | 4.55 (0.83) | 4.25 (0.84) | 4.39 (1.06) | 5.06 (1.08) |
| Triglycerides (mmol/L) | 0.96 (0.42) | 1.45 (1.52) | 1.19 (0.71) | 2.1 (1.61) |
| LDL (mmol/L) | 2.96 (0.71) | 2.78 (0.94) | 3.06 (1.05) | 3.33 (1.04) |
| LH (IU/L) | 17.04 (16.4) | 13.8 (14.6) | 6.10 (8.86) | 6.14 (8.27) |
| FSH (IU/L) | 25.23 (24.8) | 23.5 (31.9) | 10.1 (21.9) | 7.21 (12.40) |
| TSH (mIU/L) | 2.19 (1.46) | 2.62 (1.72) | 1.87 (0.98) | 2.39 (1.06) |
| Testosterone (nmol/L) | 0.70 (0.72) | 0.74 (1.23) | 26.0 (10.02) | 19.9 (9.4) |
| Estradiol (pmol/L) | 487 (539) | 586 ( 533) | 182.3 (85.8) | 183.9 (69.9) |
| SHBG (nmol/L) | 64.3 (31.7) | 70.7 (41.32) | 30.9 (12.4) | 31.2 (7.2) |
aNot included due to smoking (n = 3), refusal to participate (n = 1), dropout (n = 5), lives in distant region of the country (n = 1), cortisone treatment (n = 1), not orchidectomized (n = 4) and low compliance with hormone therapy (n = 1).
bNot included due to smoking (n = 3), refusal to participate (n = 2), dropout (n = 8), lives in distant region of the country (n = 5), ongoing glucocorticoid therapy (n = 2) and ongoing infection (conjunctivitis, n = 1 and sinusitis, n = 1)
FSH, follicle-stimulating hormone; LDL, low density lipoproteins; LH, luteinizing hormone; SHBG, sex hormone binding globulin; TM, transgender men; TSH, thyroid-stimulating hormone; TW, transgender women.